Foghorn Therapeutics Inc. (FHTX) vs TuHURA Biosciences, Inc. (HURA)

A side-by-side comparison of Foghorn Therapeutics Inc. and TuHURA Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FHTX vs HURA

growth of $100 · dividends reinvested · last 6y
FHTX -89.0% (-30.7%/yr)HURA -97.5% (-46.0%/yr)FHTX compounded faster over this window
050100150Start $100202120222023202420252026$11$2
FHTX HURA

FHTX vs HURA: by the numbers

  • •HURA is the larger company ($121M vs $112M market cap).
  • •Both run net losses; HURA's is the smaller (0.00% vs -175.78% net margin).

Metrics side by side

Valuation

MetricFHTXHURA
P/S ratio3.05N/A
P/B ratioN/A6.62

Profitability

MetricFHTXHURA
Gross margin89.22%0.00%
Operating margin-265.64%0.00%
Net margin-175.78%0.00%
ROEN/A-165.57%
ROIC-44.81%-137.40%

Growth (annualized)

MetricFHTXHURA
Revenue CAGR (5Y)105.83%N/A
Total return CAGR (5Y)-31.87%-45.49%

Frequently asked

How have FHTX and HURA total returns compared?
Over the past 5 years, FHTX delivered -31.87% and HURA delivered -45.49% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.